85-6086-15 [取扱停止]Influenza B Nucleoprotein, Recombinant [B/Beijing/184/93] 100ug 497178

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Of the three types of influenza virus (A, B and C) A is the best characterized and the most serious threat to public health. One of the three core Influenza polypeptides is an RNA-dependent RNA polymerase and a single-strand RNA (ssRNA) binding protein, often referred to as a nucleoprotein (NP). NP encapsidates the virus genome to form a ribonucleoprotein (RNP) particle for the purposes of transcription and packaging. NP is not just the structural component of the virus transcription machinery but performs multiple essential functions throughout the virus life cycle (Portela & Digard, 2002). Influenza A virus RNA segment 5 encodes NP is a polypeptide of 498aa in length; in influenza B and C viruses, the length of the homologous NP polypeptide is 560aa and 565aa residues, respectively (Londo et al., 1983; Nakada et al., 1984). Alignment of the predicted amino acid sequences of the NP genes of the three influenza virus types reveals significant similarity among the three proteins, with the type A and B NPs showing the highest degree of conservation. Phylogenetic analysis of virus strains isolated from different hosts reveals that the NP gene is also well conserved, with a maximum amino acid difference of less than 11% (Shu et al., 1993). The primary sequence of NP is modified by phosphorylation (Privalsky & Penhoet, 1978) and the phosphopeptide pattern of NP is strain-specific, dependent on the host cell used for propagating the virus and changes throughout virus replication (Kistner et al., 1985, 1989). Seasonal influenza viruses display high variability and because of the threat of influenza viruses with pandemic potential, there is great interest in the development of vaccines that induce broadly protective immunity, such as those based on conserved proteins, including nucleoprotein. NP has also been shown to induce cross-reactive antibody and T cell responses (Altenburg et al., 2017).
  • Source:Recombinant protein corresponding to Influenza B Nucleoprotein, strain Influenza B/Beijing/184/93, expressed in E. coli.
  • Storage and Stability:Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ug
  • Source Antigen:Recombinant, E. coli
  • Grade:Highly Purified
  • Purity:≥90%
  • Form:Supplied as a liquid in Tris, pH 8.0, 0.09% sodium azide.
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-6086-15
型番
497178
入り数
1個
標準価格
199,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る